131 related articles for article (PubMed ID: 1607002)
1. Pharmacokinetics of vinorelbine in man.
Marquet P; Lachatre G; Debord J; Eichler B; Bonnaud F; Nicot G
Eur J Clin Pharmacol; 1992; 42(5):545-7. PubMed ID: 1607002
[TBL] [Abstract][Full Text] [Related]
2. Blood and plasma pharmacokinetics of vinorelbine in elderly patients with advanced metastatic cancer.
Gauvin A; Pinguet F; Culine S; Astre C; Cupissol D; Bressolle F
Cancer Chemother Pharmacol; 2002 Jan; 49(1):48-56. PubMed ID: 11855752
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic, bioavailability, and feasibility study of oral vinorelbine in patients with solid tumors.
Rowinsky EK; Noe DA; Trump DL; Winer EP; Lucas VS; Wargin WA; Hohneker JA; Lubejko B; Sartorius SE; Ettinger DS
J Clin Oncol; 1994 Sep; 12(9):1754-63. PubMed ID: 8083697
[TBL] [Abstract][Full Text] [Related]
4. The clinical pharmacokinetics of vinorelbine (Navelbine).
Wargin WA; Lucas VS
Semin Oncol; 1994 Oct; 21(5 Suppl 10):21-7. PubMed ID: 7973765
[TBL] [Abstract][Full Text] [Related]
5. Bayesian pharmacokinetic estimation of vinorelbine in non-small-cell lung cancer patients.
Sabot C; Marquet P; Debord J; Carpentier N; Merle L; Lachâtre G
Eur J Clin Pharmacol; 1998 Apr; 54(2):171-5. PubMed ID: 9626924
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of navelbine after oral administration in cancer patients.
Zhou XJ; Boré P; Monjanel S; Sahnoun Z; Favre R; Durand A; Rahmani R
Cancer Chemother Pharmacol; 1991; 29(1):66-70. PubMed ID: 1742851
[TBL] [Abstract][Full Text] [Related]
7. Clinical pharmacokinetics of vinorelbine.
Levêque D; Jehl F
Clin Pharmacokinet; 1996 Sep; 31(3):184-97. PubMed ID: 8877249
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic profile of vinorelbine, a new semi-synthetic vinca alkaloid, determined by high-performance liquid chromatography.
Levêque D; Jehl F; Quoix E; Monteil H
Xenobiotica; 1993 Nov; 23(11):1325-33. PubMed ID: 8310715
[TBL] [Abstract][Full Text] [Related]
9. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic evaluation of the vinorelbine-lapatinib combination in the treatment of breast cancer patients.
Rezai K; Urien S; Isambert N; Roche H; Dieras V; Berille J; Bonneterre J; Brain E; Lokiec F
Cancer Chemother Pharmacol; 2011 Dec; 68(6):1529-36. PubMed ID: 21519841
[TBL] [Abstract][Full Text] [Related]
11. Population pharmacokinetics of short intravenous vinorelbine infusions in patients with metastatic breast cancer.
Deporte-Fety R; Simon N; Fumoleau P; Campone M; Kerbrat P; Bonneterre J; Fargeot P; Urien S
Cancer Chemother Pharmacol; 2004 Mar; 53(3):233-8. PubMed ID: 14634791
[TBL] [Abstract][Full Text] [Related]
12. Bayesian estimate of vinorelbine pharmacokinetic parameters in elderly patients with advanced metastatic cancer.
Gauvin A; Pinguet F; Culine S; Astre C; Gomeni R; Bressolle F
Clin Cancer Res; 2000 Jul; 6(7):2690-5. PubMed ID: 10914711
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary distribution of vinorelbine in patients with non-small-cell lung cancer.
Levêque D; Quoix E; Dumont P; Massard G; Hentz JG; Charloux A; Jehl F
Cancer Chemother Pharmacol; 1993; 33(2):176-8. PubMed ID: 8261579
[TBL] [Abstract][Full Text] [Related]
14. Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology Group.
Johansen M; Kuttesch J; Bleyer WA; Krailo M; Ames M; Madden T
Clin Cancer Res; 2006 Jan; 12(2):516-22. PubMed ID: 16428494
[TBL] [Abstract][Full Text] [Related]
15. Oral vinorelbine (Navelbine) in the treatment of advanced breast cancer.
Winer EP; Chu L; Spicer DV
Semin Oncol; 1995 Apr; 22(2 Suppl 5):72-8; discussion 78-9. PubMed ID: 7740337
[TBL] [Abstract][Full Text] [Related]
16. Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography.
van Tellingen O; Kuijpers AV; Beijnen JH; Nooijen WJ; Bult A
Invest New Drugs; 1993; 11(2-3):141-50. PubMed ID: 8262726
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of [3H]navelbine in patients: comparative pharmacokinetics using radioactive and radioimmunologic determination methods.
Rahmani R; Zhou XJ; Boré P; Van Cantfort J; Focan C; Cano JP
Anticancer Drugs; 1991 Aug; 2(4):405-10. PubMed ID: 1797198
[TBL] [Abstract][Full Text] [Related]
18. Vinorelbine: a novel vinca alkaloid.
Toso C; Lindley C
Am J Health Syst Pharm; 1995 Jun; 52(12):1287-304; quizz 1340-1. PubMed ID: 7656116
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of vinorelbine in patients with liver metastases.
Robieux I; Sorio R; Borsatti E; Cannizzaro R; Vitali V; Aita P; Freschi A; Galligioni E; Monfardini S
Clin Pharmacol Ther; 1996 Jan; 59(1):32-40. PubMed ID: 8549031
[TBL] [Abstract][Full Text] [Related]
20. A limited-sampling strategy to estimate individual pharmacokinetic parameters of vinorelbine in elderly patients with advanced metastatic cancer.
Gauvin A; Pinguet F; Culine S; Astre C; Gomeni R; Bressolle F
Anticancer Drugs; 2002 Jun; 13(5):473-80. PubMed ID: 12045458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]